Camlin Fine Sciences

Tariff Benefits And Safety Trends Will Boost US And Europe

AnalystConsensusTarget

Not Invested

Based on Analyst Price Targets

Published

04 Sep 25

AnalystConsensusTarget's Fair Value

₹295.00

32.4% undervalued

04 Sep

₹199.35

97.7%

3.0%

97.7%

3.0%

You can edit this narrative until Sep 4 8:11 PM. Then, changes will post as Updates.

Author's Valuation

₹29532.4% undervalued

AnalystConsensusTarget Fair Value

Narrative

Updates0

AnalystConsensusTarget Fair Value

₹295

32.4% undervalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

16.24%

Chemicals revenue growth rate

0.66%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

14.05%

Calculation

₹3.31b

Earnings '28

34.94x

PE Ratio '28

₹115.66b

Market Cap '28

₹115.66b

Market Cap '28

264.94m

No. shares '28

₹436.55

Share Price '28

₹436.55 Share Price '28

Discounted to 2025 @ 13.96% p.a.

₹294.98

Fair Value '25